Preclinical study suggests the compound could restore lost muscle for patients with the rare degenerative disorder A novel drug holds promise for treating Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes severe muscle degeneration.   McGill University researchers have discovered that an experimental compound called K884 can boost…